Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Ho

Showing results (41-50 of 192) with videos related to

Pageof 20
Sort By:
Expert Opinion on Emerging Drugs|March 8, 2021
Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trialsAmna Majeed, Jiaqi Xiong, Kayla M Teopiz, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|November 2, 2019
Smartphone applications for the treatment of depressive symptoms: A meta-analysis and qualitative reviewCaroline Park, Judy Zhu, Roger Ho Chun Man, et al.
Expert Opinion on Drug Safety|May 3, 2022
A review of potential neuropathological changes associated with ketamineDanica Nogo, Hana Nazal, Yuetong Song, et al.
Annals of the Academy of Medicine, Singapore|June 26, 2024
Consensus statements and guideline for the diagnosis and management of plantar fasciitis in SingaporeVictor Aik Khien Tan, Chin Chuen Tan, Nicholas Eng Meng Yeo, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
Predictors of Psychological Distress across Three Time Periods during the COVID-19 Pandemic in PolandAgata Chudzicka-Czupała, Soon-Kiat Chiang, Damian Grabowski, et al.
Expert Review of Clinical Pharmacology|October 21, 2023
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophreniaJie Wu, Angela Th Kwan, Taeho Greg Rhee, et al.
Neuroscience and Biobehavioral Reviews|August 4, 2018
Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developmentsElisa Brietzke, Rodrigo B Mansur, Mehala Subramaniapillai, et al.
Journal of Affective Disorders|June 11, 2025
Network-based alterations in task-induced functional connectivity in bipolar disorder: An functional near-infrared spectroscopy studySeongyeon Lim, Suh-Yeon Dong, Bach Xuan Tran, et al.
Journal of Affective Disorders|November 29, 2025
The association between depressive symptom severity and metabolic disturbances in major depressive and bipolar disorders: A systematic review and meta-analysisSabrina Wong, Gia Han Le, Hernan F Guillen-Burgos, et al.
Comprehensive Psychiatry|August 13, 2019
Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with VortioxetineMehala Subramaniapillai, Rodrigo B Mansur, Hannah Zuckerman, et al.
Pageof 20

Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
Expert Opinion on Emerging Drugs|March 8, 2021
Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trialsAmna Majeed, Jiaqi Xiong, Kayla M Teopiz, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|November 2, 2019
Smartphone applications for the treatment of depressive symptoms: A meta-analysis and qualitative reviewCaroline Park, Judy Zhu, Roger Ho Chun Man, et al.
Expert Opinion on Drug Safety|May 3, 2022
A review of potential neuropathological changes associated with ketamineDanica Nogo, Hana Nazal, Yuetong Song, et al.
Annals of the Academy of Medicine, Singapore|June 26, 2024
Consensus statements and guideline for the diagnosis and management of plantar fasciitis in SingaporeVictor Aik Khien Tan, Chin Chuen Tan, Nicholas Eng Meng Yeo, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
Predictors of Psychological Distress across Three Time Periods during the COVID-19 Pandemic in PolandAgata Chudzicka-Czupała, Soon-Kiat Chiang, Damian Grabowski, et al.
Expert Review of Clinical Pharmacology|October 21, 2023
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophreniaJie Wu, Angela Th Kwan, Taeho Greg Rhee, et al.
Neuroscience and Biobehavioral Reviews|August 4, 2018
Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developmentsElisa Brietzke, Rodrigo B Mansur, Mehala Subramaniapillai, et al.
Journal of Affective Disorders|June 11, 2025
Network-based alterations in task-induced functional connectivity in bipolar disorder: An functional near-infrared spectroscopy studySeongyeon Lim, Suh-Yeon Dong, Bach Xuan Tran, et al.
Journal of Affective Disorders|November 29, 2025
The association between depressive symptom severity and metabolic disturbances in major depressive and bipolar disorders: A systematic review and meta-analysisSabrina Wong, Gia Han Le, Hernan F Guillen-Burgos, et al.
Comprehensive Psychiatry|August 13, 2019
Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with VortioxetineMehala Subramaniapillai, Rodrigo B Mansur, Hannah Zuckerman, et al.
Pageof 20